Better Therapeutics
Stock Forecast, Prediction & Price Target

Better Therapeutics Financial Estimates

Better Therapeutics Revenue Estimates

Better Therapeutics EBITDA Estimates

Better Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2020 12/31/2021 12/31/2022 12/31/2025 12/31/2026 12/31/2027
Revenue
 
% change YoY
$8K
 
N/A
$0
 
-100%
$0
 
0%
Avg: $18.8M
Low: $18.8M
High: $18.8M
avg. 0%
Avg: $15.34M
Low: $15.34M
High: $15.34M
avg. -18.39%
Avg: $44.90M
Low: $44.90M
High: $44.90M
avg. 192.68%
Net Income
 
% change YoY
$-6.38M
 
N/A
$-40.33M
 
-531.51%
$-39.76M
 
1.42%
Avg: $-34.03M
Low: $-25.44M
High: $-25.44M
avg. 14.40%
Avg: $-16.25M
Low: $-16.25M
High: $-16.25M
avg. 52.23%
Avg: $-10.60M
Low: $-10.60M
High: $-10.60M
avg. 34.78%
EBITDA
 
% change YoY
$-6.24M
 
N/A
$-30.56M
 
-389.11%
$-38.26M
 
-25.20%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.85
 
N/A
-$1.71
 
-101.17%
-$1.69
 
1.16%
Avg: -$1.08
Low: -$1.08
High: -$1.08
avg. 36.09%
Avg: -$0.69
Low: -$0.69
High: -$0.69
avg. 36.11%
Avg: -$0.45
Low: -$0.45
High: -$0.45
avg. 34.78%
Operating Expenses
 
% change YoY
$5.64M
 
N/A
$30.56M
 
440.98%
$38.26M
 
25.20%
Avg: $2.25B
Low: $2.25B
High: $2.25B
avg. 5802.16%
Avg: $1.84B
Low: $1.84B
High: $1.84B
avg. -18.39%
Avg: $5.39B
Low: $5.39B
High: $5.39B
avg. 192.68%

FAQ

What is Better Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 33.80% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -25.44M, average is -34.03M and high is -25.44M.

What is Better Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 58.09% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $18.8M, average is $18.8M and high is $18.8M.

What is Better Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 35.66% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.08, average is -$1.08 and high is $-1.08.